Utilization of a structured research site mentorship model to facilitate site performance in a clinical research network

IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Contemporary Clinical Trials Communications Pub Date : 2025-04-01 Epub Date: 2024-12-31 DOI:10.1016/j.conctc.2024.101423
Marcus R. Johnson , Danielle Beck , Melyssa Sueiro , Makaila Decker , Jeff Newcomb , Margaret Tiktin , Amelia Kiliveros , Aliya Asghar
{"title":"Utilization of a structured research site mentorship model to facilitate site performance in a clinical research network","authors":"Marcus R. Johnson ,&nbsp;Danielle Beck ,&nbsp;Melyssa Sueiro ,&nbsp;Makaila Decker ,&nbsp;Jeff Newcomb ,&nbsp;Margaret Tiktin ,&nbsp;Amelia Kiliveros ,&nbsp;Aliya Asghar","doi":"10.1016/j.conctc.2024.101423","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Research site mentorship has a positive impact on study enrollment. The VA Cooperative Studies Program's (CSP) Network of Dedicated Enrollment Sites (NODES) utilized an existing site mentorship model to onboard 13 new expansion sites. We describe the successes, challenges, and lessons learned during the development and implementation of this model in this paper.</div></div><div><h3>Methods</h3><div>NODES established a “Site Mentorship/Expansion Workgroup (SWG)” in October 2020 to plan and guide the consortium on providing mentorship and services to other clinical research networks, non-Node CSP study sites, and NODES expansion sites. In 2021, the SWG developed a 12-month implementation plan to onboard 13 new sites by pairing original Node (mentor) sites with expansion Node (mentee) sites. Mentors offered prompt guidance and solutions to mentees on site-level challenges by working with them closely. Implementation of the plan occurred from February 2022 through September 2023.</div></div><div><h3>Results</h3><div>Data from the implementation of this mentorship plan demonstrated a 32.7 % increase (from 54.8 % in 2022 to 87.5 % in 2023) in the expansion sites’ achievement of their Objectives &amp; Key Results (OKRs). From October 2020–September 2021, prior to mentorship assignments, the original sites (mentors) achieved an average of 88 % of their OKRs and attained an average of 86.7 % and 80.9 % of those OKRs in October–September of 2022 and 2023 respectively during the mentorship implementation phase.</div></div><div><h3>Conclusions</h3><div>The results demonstrate that developing and implementing a research site mentorship model to facilitate onboarding and performance of research sites into an established network was feasible and contributed to the success of those sites.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"44 ","pages":"Article 101423"},"PeriodicalIF":1.4000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782873/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary Clinical Trials Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451865424001704","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/31 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Research site mentorship has a positive impact on study enrollment. The VA Cooperative Studies Program's (CSP) Network of Dedicated Enrollment Sites (NODES) utilized an existing site mentorship model to onboard 13 new expansion sites. We describe the successes, challenges, and lessons learned during the development and implementation of this model in this paper.

Methods

NODES established a “Site Mentorship/Expansion Workgroup (SWG)” in October 2020 to plan and guide the consortium on providing mentorship and services to other clinical research networks, non-Node CSP study sites, and NODES expansion sites. In 2021, the SWG developed a 12-month implementation plan to onboard 13 new sites by pairing original Node (mentor) sites with expansion Node (mentee) sites. Mentors offered prompt guidance and solutions to mentees on site-level challenges by working with them closely. Implementation of the plan occurred from February 2022 through September 2023.

Results

Data from the implementation of this mentorship plan demonstrated a 32.7 % increase (from 54.8 % in 2022 to 87.5 % in 2023) in the expansion sites’ achievement of their Objectives & Key Results (OKRs). From October 2020–September 2021, prior to mentorship assignments, the original sites (mentors) achieved an average of 88 % of their OKRs and attained an average of 86.7 % and 80.9 % of those OKRs in October–September of 2022 and 2023 respectively during the mentorship implementation phase.

Conclusions

The results demonstrate that developing and implementing a research site mentorship model to facilitate onboarding and performance of research sites into an established network was feasible and contributed to the success of those sites.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用结构化的研究站点指导模型来促进临床研究网络中的站点性能。
研究背景:研究现场指导对研究入组有正向影响。退伍军人事务部合作研究项目(CSP)的专用注册站点网络(NODES)利用现有的站点指导模式,将13个新的扩展站点纳入其中。在本文中,我们描述了在开发和实现该模型过程中的成功、挑战和经验教训。方法:NODES于2020年10月成立了一个“站点指导/扩展工作组(SWG)”,以规划和指导该联盟向其他临床研究网络、非node CSP研究站点和NODES扩展站点提供指导和服务。2021年,SWG制定了一项为期12个月的实施计划,通过将原始节点(导师)站点与扩展节点(学员)站点配对,将13个新站点纳入其中。导师通过与学员密切合作,在现场层面的挑战上提供及时的指导和解决方案。该计划于2022年2月至2023年9月期间实施。结果:该指导计划的实施数据显示,扩展站点实现其目标和关键结果(okr)的比例增加了32.7%(从2022年的54.8%增加到2023年的87.5%)。从2020年10月至2021年9月,在导师分配之前,原始站点(导师)平均实现了88%的okr,在2022年10月至9月和2023年10月至9月分别达到了86.7%和80.9%的okr。结论:研究结果表明,开发和实施一个研究站点指导模式,以促进研究站点的入职和绩效进入一个既定的网络是可行的,并有助于这些站点的成功。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
2.70
自引率
6.70%
发文量
146
审稿时长
20 weeks
期刊介绍: Contemporary Clinical Trials Communications is an international peer reviewed open access journal that publishes articles pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from a wide range of disciplines including medicine, life science, pharmaceutical science, biostatistics, epidemiology, computer science, management science, behavioral science, and bioethics. Contemporary Clinical Trials Communications is unique in that it is outside the confines of disease specifications, and it strives to increase the transparency of medical research and reduce publication bias by publishing scientifically valid original research findings irrespective of their perceived importance, significance or impact. Both randomized and non-randomized trials are within the scope of the Journal. Some common topics include trial design rationale and methods, operational methodologies and challenges, and positive and negative trial results. In addition to original research, the Journal also welcomes other types of communications including, but are not limited to, methodology reviews, perspectives and discussions. Through timely dissemination of advances in clinical trials, the goal of Contemporary Clinical Trials Communications is to serve as a platform to enhance the communication and collaboration within the global clinical trials community that ultimately advances this field of research for the benefit of patients.
期刊最新文献
(Cost-)Effectiveness of personalised multimodal physiotherapy compared to surgery in patients with painful cervical radiculopathy. Protocol for a randomised non-inferiority trial (The MOVE-IT study) Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases A combined progressive muscle relaxation and walking intervention for adults with end-stage kidney disease receiving hemodialysis (Fight Fatigue): Study development and protocol Improving representativeness in trial recruitment: A data-driven approach Diversity in clinical Trials: The example of systemic lupus erythematosus
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1